Search
No relevant pages have been found
Number of relevant news: 2
Phase 2 drug trial offers hope to patients with advanced colorectal cancer
colorectal cancer, survival time...
Breast cancer gene provides vital clue to bowel cancer drug resistance
had a partial response to treatment and moderate survival time (9.7 months on average). Dr Milo Frattini, lead researcher from the...